FDA Inspection 1030806 — Huazhong Pharmaceutical Co., Ltd
The FDA completed an inspection of Huazhong Pharmaceutical Co., Ltd on September 21, 2017 in Xiangyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xiangyang (China)